Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Rosenkamp Clinical Trials Website:

"Roskamp Institute Clinical Trials Experience

Under the leadership of the Institute’s Scientific Director, Michael Mullan, MBBS, Ph.D., along with our clinical investigative team headed by Andrew Keegan, MD, a renowned neurologist, Roskamp has extensive expertise in a multitude of therapeutic areas and phases of pharmaceutical/nutraceutical clinical research. Our clinical research coordinators and nurses, many of whom are certified, are highly experienced in all aspects of clinical trials including regulatory issues, recruitment, and accurate record maintenance. Our goal is to provide excellent trial-related patient care, while meeting contract goals and sponsor timelines. Our research is conducted with strict adherence to Federal Drug Administration (FDA), International Conference of Harmonization (ICH), Good Clinical Practice (GCP) and HIPPA guidelines.

We perform primarily phase II - IV clinical research studies. Specific areas of study include:

Alzheimer's Disease (actively enrolling)

Elan Agitation Study

Accera AD Trial

TauRx AD Study

Multiple Sclerosis (actively enrolling)

RRMS Novartis Cognition study

RR<S Novartis PREFER Study

RRMS Novartis ASSESS study

Dementia Mild Cognitive Impairment (MCI)

Depression

Head and Traumatic Brain Injury

Migraine

Neurodegenerative disease

Neuromuscular disordersParkinson's Disease

Tourette's Syndrome

Other psychiatric and central nervous system conditions

Bipolar DisorderGeneral Anxiety Disorder


For more information on clinical trials, contact:

Roskamp Institute Clinical Trials
2040 Whitfield Avenue
Sarasota, FL 34243

Phone: [phone]
Fax: [phone]

Email: Clinical Trials Division

Roskamp Institute Memory Clinic
2040 Whitfield Avenue
Sarasota, FL 34243

Phone: [phone]
Fax: [phone]

Email: Clinical Trials Division

Webpage at:
http://www.rfdn.org/clinical_trials.html